September 2022 - Notice of Allowance for First Patent
SentryX received a Notice of Allowance from the United States Patent and Trademark Office for its first patent application. Previously, the patent also received an Intention to Grant status from the European Patent Office. These two milestones represent highly important steps towards the global protection of both SentryX’s surgical applications and their underlying hydrogel technology. Presently, SentryX has submitted six patent applications.